GO Term | Evidence Code | PMID |
---|---|---|
regulation of meiotic nuclear division | ||
intracellular calcium ion homeostasis |
|
|
response to xenobiotic stimulus | ||
cellular response to electrical stimulus | ||
regulation of transcription, DNA-templated |
|
GO Term | Evidence Code | PMID |
---|---|---|
DNA binding |
|
|
integrin binding | ||
zinc ion binding |
|
|
nuclear androgen receptor binding | ||
protein folding chaperone |
|
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:5075 | myxopapillary ependymoma | |
DOID:5076 | mixed glioma | |
DOID:5077 | subependymal giant cell astrocytoma | |
DOID:5082 | liver cirrhosis | |
DOID:5162 | arteriolosclerosis | |
DOID:5199 | ureteral obstruction | |
DOID:5339 | cyclic hematopoiesis | |
DOID:5403 | microcystic adenoma | |
DOID:5409 | lung small cell carcinoma | |
DOID:5418 | schizoaffective disorder |
HPO ID | HPO Term |
---|---|
HP:0002039 | Anorexia |
HP:0002040 | Esophageal varix |
HP:0002076 | Migraine |
HP:0002239 | Gastrointestinal hemorrhage |
HP:0002240 | Hepatomegaly |
HP:0002315 | Headache |
HP:0002321 | Vertigo |
HP:0002326 | Transient ischemic attack |
HP:0002488 | Acute leukemia |
HP:0002586 | Peritonitis |
Disease ID | Disease Name |
---|---|
ORPHA:824 |
|
OMIM:254450 |
|
ORPHA:3318 |
|
OMIM:187950 |
|
ORPHA:131 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
178997 | WB:WBGene00000802 | ||
41166 | FB:FBgn0005585 | ||
325317 | ZFIN:ZDB-GENE-030131-4042 | DANRE43330 | |
108265943 | ICTPU29931 | ||
113581087 | ELEEL27705 | ||
106599148 | SALSA112940 | ||
115156816 | SALTR62730 | ||
115158393 | SALTR109455 | ||
115169886 | SALTR41851 | ||
115192495 | SALTR30222 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024